A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab as Maintenance Therapy Following Standard Chemotherapy for Patients with High/High-intermediate risk Diffu...

por Reddy, Nishitha M., Greer, John P., Morgan, David S., Chen, Heidi, Park, Steven I., Richards, Kristy L.
Publicado 2016

Six Month Freedom from Treatment Failure is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials

por Sengsayadeth, Salyka, Savani, Bipin N., Jagasia, Madan, Goodman, Stacey, Greer, John P., Chen, Heidi, Chinratanalab, Wichai, Kassim, Adetola A., Engelhardt, Brian G.
Publicado 2013

Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant

por Patel, Dilan A., Mendoza, Karina A., Chen, Heidi, Engelhardt, Brian G., Savani, Bipin N., Goodman, Stacey A., Warner, Jeremy, Kassim, Adetola A., Byrne, Michael, Chinratanalab, Wichai, Greer, John P., Hunt, Carole, Jagasia, Madan
Publicado 2021

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy

por Shiuan, Eileen, Beckermann, Kathryn E., Ozgun, Alpaslan, Kelly, Ciara, McKean, Meredith, McQuade, Jennifer, Thompson, Mary Ann, Puzanov, Igor, Greer, John P., Rapisuwon, Suthee, Postow, Michael, Davies, Michael A., Eroglu, Zeynep, Johnson, Douglas
Publicado 2017

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

por Li, Xuanyi, Sigworth, Elizabeth A., Wu, Adrianne H., Behrens, Jess, Etemad, Shervin A., Nagpal, Seema, Go, Ronald S., Wuichet, Kristin, Chen, Eddy J., Rubinstein, Samuel M., Venepalli, Neeta K., Tillman, Benjamin F., Cowan, Andrew J., Schoen, Martin W., Malty, Andrew, Greer, John P., Fernandes, Hermina D., Seifter, Ari, Chen, Qingxia, Chowdhery, Rozina A., Mohan, Sanjay R., Dewdney, Summer B., Osterman, Travis, Ambinder, Edward P., Buchbinder, Elizabeth I., Schwartz, Candice, Abraham, Ivy, Rioth, Matthew J., Singh, Naina, Sharma, Sanjai, Gibson, Michael K., Yang, Peter C., Warner, Jeremy L.
Publicado 2020

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and min...

por Bachanova, Veronika, Marks, David I., Zhang, Mei-Jie, Wang, Hailin, de Lima, Marcos, Aljurf, Mahmoud D., Arellano, Martha, Artz, Andrew S., Bacher, Ulrike, Cahn, Jean-Yves, Chen, Yi-Bin, Copelan, Edward A., Drobyski, William R., Gale, Robert Peter, Greer, John P, Gupta, Vikas, Hale, Gregory A., Kebriaei, Partow, Lazarus, Hillard M., Lewis, Ian D., Lewis, Victor A., Liesveld, Jane L., Litzow, Mark R., Loren, Alison W., Miller, Alan M., Norkin, Maxim, Oran, Betul, Pidala, Joseph, Rowe, Jacob M., Savani, Bipin N., Saber, Wael, Vij, Ravi, Waller, Edmund K., Wiernik, Peter H., Weisdorf, Daniel J.
Publicado 2013